Open tender · Germany · Pharmaceutical products
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Interferon beta-1a (ATC-Code nach WHO: L03AB07)
In EnglishConclusion of non-exclusive drug discount agreement under § 130a para. 8 SGB V via an Open-House model for the active ingredient Interferon beta-1a (ATC code according to WHO: L03AB07)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen in Germany is inviting bids for “Conclusion of non-exclusive drug discount agreement under § 130a para. 8 SGB V via an Open-House model for the active ingredient Interferon beta-1a…”. Bids close on 30 June 2027, 23:59 CEST. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Non-exclusive discount agreements for Interferon beta-1a via an Open-House model with no individual negotiations or exclusivity.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 0 requirements to qualify and the 4 documents a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences